Home › Funds › Logos Global Management LP › IMVT

Logos Global Management LP position in IMVT

IMMUNOVANT INC · Health Care

Logos Global Management LP reported holding 665,000 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$25.6M, representing 1.10% of its reported portfolio and ranking #30 among its reported holdings. Logos Global Management LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)665.00K sh
Reported value held$25.62M
Portfolio Weight1.10%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's IMVT position evolved

Logos Global Management LP first disclosed a stake in IMVT in Q3 2023 at 1,600,000 shares (US$61.4M). Across 12 filings, Logos Global Management LP increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 665,000 shares valued at US$25.6M — a reduction of -410,000 shares quarter over quarter.. Notable position changes include a 91% increase in Q3 2024 (shares fell 13% over the following quarter), a 73% trim in Q4 2024 (shares fell 31% over the following quarter), a 400% increase in Q4 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.60M $61.42M New
Q4 2023 1.20M $50.56M Reduce
Q1 2024 1.77M $57.35M Add
Q2 2024 575.00K $15.18M Reduce
Q3 2024 1.10M $31.36M Add
Q4 2024 300.00K $7.43M Reduce
Q1 2025 275.00K $4.70M Reduce
Q2 2025 275.00K $4.40M Hold
Q3 2025 275.00K $4.43M Hold
Q4 2025 1.38M $34.95M Add
Q1 2026 1.07M $26.70M Reduce
Q2 2026 665.00K $25.62M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has Logos Global Management LP held IMVT?

Logos Global Management LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Logos Global Management LP's current position in IMVT?

As of Q2 2026, Logos Global Management LP holds 665.00K shares of IMVT (IMMUNOVANT INC), valued at $25.62M, representing 1.10% of its reported portfolio and ranking #30.

Has Logos Global Management LP been buying or selling IMVT?

In the latest 13F filing (Q2 2026), Logos Global Management LP reduced its position in IMVT.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.